It’s possible that you might get a false-positive or a false-negative.”15 A second AI-enabled decision aid, ALProst®, offered personalised insights on the benefits and risks of prostate cancer screening for an individual patient, based on their prostate-specific antigen (PSA) test result and age24. This evidence concerns the gene KLK3 and prostate carcinoma.